Browsing by Author MORGENSTERN ALFRED

Showing results 1 to 20 of 31  next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2008JRC45708213Bi (Alpha-emitter)-Antibody Targeting of Breast Cancer Metastases in the neu-N Transgenic Mouse ModelSONG H.; SHAHVERDI K.; HUSO D. L.; ESAIAS C.; FOX J.; LIEDY A.; ZHANG Z.; REILLY R. T.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED, et alArticles in periodicals and books
2007JRC38225213bi-Induced Death of Hsc45-M2 Gastric Cancer Cells Is Characterized by G2 Arrest and Up-Regulation of Genes Known to Prevent Apoptosis but Induce Necrosis and Mitotic CatastrpopheSEIDL C.; PORT M.; GILBERTZ K.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER M.; ROEPER B.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M.Articles in periodicals and books
2007JRC41950213Bi-radioimmunotherapy Defeats Early-stage Disseminated Gastric Cancer in Nude MiceBECK R.; SEIDL C.; PFOST B.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BAUM M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2006JRC33735Antibody-guided Alpha Radiation Effectively Damages Fungal BiofilmsMARTINEZ L.r.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; CASADEVALL A.; DADACHOVA E.Articles in periodicals and books
2017JRC105961Assessment of 213Bi-anti-EGFR-MAb treatment response in malignant cancer cellsFEUERECKER BENEDIKT; RANDL PHILIPP; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SCHWAIGER M.; EISENREICH WOLFGANGArticles in periodicals and books
2017JRC105960Barium ferrite nanoparticles labeled with 223Ra: a new potential radiobioconjugate for internal alpha therapyMALISZEWSKA W; CĘDROWSKA E; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BILEWICZ ALEKSANDERArticles in periodicals and books
2007JRC37152Breaking Chemo- and Radioresistance with [Bi-213]anti-CD45 Antibodies in Leukemia CellsFRIESEN C.; GLATTING G.; KOOP B.; SCHWARZ K.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; DEBATIN K.m.; RESKE S.n.Articles in periodicals and books
2006JRC35134Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha RadioimmunoconjugatesWANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j., et alArticles in periodicals and books
2005JRC30447Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; MOELLENBECK J.; MORGENSTERN ALFRED; ABBAS KAMELArticles in periodicals and books
2005JRC32186Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; ABBAS KAMEL; MOELLENBECK J.; MORGENSTERN ALFREDArticles in periodicals and books
2008JRC44968The Cytokinesis-Block Micronucleus Assay as a Biological Dosimeter for Targeted Alpha TherapySONG E.; RIZVI S.; QU C. F.; RAJA C.; YUEN J.; LI Y.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in periodicals and books
2006JRC33597Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and ClustersSONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J.Articles in periodicals and books
2008JRC44967Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian CancerKNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C.Articles in periodicals and books
2005JRC30250Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse Type Gastric Cancer Using A 213BI-conjugated Monoclonal AntibodyBLOECHEL S.; BECK R.; SEIDL C.; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2007JRC41945Gemcitabine Radiosensitizes Multiple Myeloma Cells to Low LET, but not High LET, IrradiationSUPIOT S.; THILLAYS F.; RIO E.; GOUARD S.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; MAHE M. A.; CHATAL J. F.; DAVODEAU F.; CHEREL M.Articles in periodicals and books
2017JRC106152The impact of tumor burden on the absorbed dose to the kidneys from Actinium-225 labeled antibody therapy in a murine model and predicted dosimetric impact for human clinical useJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.; HOBBS ROBERT F.Articles in periodicals and books
2007JRC37786An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2006JRC35382In Vitro Screening for Synergism of High-linear Energy Transfer 213Bi-radiotherapy with other Therapeutic Agents for the Treatment of B-cell Chronic Lymphocytic LeukemiaVANDENBULCKE K.; THIERENS H.; VOS F.d.; OFFNER F.; JANSSENS F.; PHILIPPE J.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; BACHER K.; DE GELDER V., et alArticles in periodicals and books
2005JRC31716In Vivo and In Vitro Inhibition of Pancreatic Cancer Growth by Targeted Alpha Therapy using 213Bi-CHX.A"-C595QU C.f.; SONG Y.j.; RIZVI S.m.a.; SMITH R.m.; PERKINS A.c.; MORGENSTERN ALFRED; BRECHBIEL M.; ALLEN Barry J.Articles in periodicals and books
2006JRC33757Interaction of Radiolabeled Antibodies with Fungal Cells and Components of Immune System In Vitro and During Radioimmunotherapy of Experimental Fungal InfectionDADACHOVA E.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; ZHANG T.; MOADEL T.; CASADEVALL A.Articles in periodicals and books